|
|
||||||||
AJP - Endocrinology and Metabolism, Vol 269, Issue 6 E1024-E1030, Copyright © 1995 by American Physiological Society
ARTICLES |
S. L. Perkins and S. J. Kling
Department of Pathology, University of Utah School of Medicine, Salt Lake City 84132, USA.
Macrophage colony-stimulating factor (M-CSF) is essential for differentiation of osteoclasts and macrophages from a common bone marrow precursor. Using ST-2 stromal cell/murine bone marrow coculture, we studied the effects of increasing amounts of M-CSF on differentiation of macrophages and osteoclasts. Addition of exogenous M-CSF caused a dose-dependent 98% decrease in tartrate-resistant acid phosphatase (TRAP)-positive multinucleated cells, accompanied by a 2.5-fold increase in nonspecific esterase-staining macrophages. Similar decrease in osteoclastic functional activity, including 125I-labeled calcitonin binding and calcitonin-stimulated adenosine 3',5'-cyclic monophosphate (cAMP) production, were observed. Addition of exogenous M-CSF beyond 6 days in coculture had a decreasing ability to inhibit osteoclast formation, suggesting that M-CSF exerts its effects early in osteoclast differentiation, during the proposed proliferative phase of osteoclast formation. Similarly, early addition of neutralizing anti-M-CSF inhibited osteoclast formation, with diminishing effects beyond day 9. These results suggest that local high concentrations of M-CSF may influence the early determination of terminal differentiation into either macrophages or osteoclasts.
This article has been cited by other articles:
![]() |
X. Fan, D. Fan, H. Gewant, C. L. Royce, M. S. Nanes, and J. Rubin Increasing membrane-bound MCSF does not enhance OPGL-driven osteoclastogenesis from marrow cells Am J Physiol Endocrinol Metab, January 1, 2001; 280(1): E103 - E111. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yasuda, N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, S.-i. Mochizuki, A. Tomoyasu, K. Yano, M. Goto, A. Murakami, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL PNAS, March 31, 1998; 95(7): 3597 - 3602. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-Q. Yao, B.-h. Sun, E. E. Hammond, E. N. Spencer, M. C. Horowitz, K. L. Insogna, and E. C. Weir The Cell-surface Form of Colony-stimulating Factor-1 Is Regulated by Osteotropic Agents and Supports Formation of Multinucleated Osteoclast-like Cells J. Biol. Chem., February 13, 1998; 273(7): 4119 - 4128. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |